Incheon City Takes off as Culture and Tourism Industry Hub in Northeast Asia with IFEZ’s Yeongjong Resort Complex Cluster
10.12.2019 15:00:00 EET | Business Wire | Press release
With rich tourism infrastructure and resources, including the world’s top-level Incheon International Airport, Ganghwa Island, open port area, and multiple islands, the Incheon Metropolitan City government plans to take off as a hub of culture and tourism industry in Northeast Asia through the Yeongjong-do Integrated Resort Cluster Project.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191210005029/en/
Incheon City plans to take off as a hub of culture and tourism industry in Northeast Asia through the Yeongjong-do Integrated Resort Cluster Project. Yeongjong International Town, where the Incheon International Airport is located, continues to expand cultural and tourism facilities. The first resort complex in Korea, the Paradise City comprises a 5-star hotel, the largest foreigners-only casino in Korea, and a convention hall that can accommodate 1,600 persons opened in 2017. To open it in 2021, the Caesars Resort Complex is under construction in Yeongjong-do by Caesars Entertainment. It will consist of a luxury hotel with over 700 rooms, casino for foreigners only, convention facilities, live entertainment performing hall, signature spa and a swimming pool. Adjacent to the Incheon International Airport, the Inspire Resort Complex is under construction led by Mohegan Gaming and Entertainment to open in 2022. (Photo: Business Wire)
Yeongjong International Town, where the Incheon International Airport is located, continues to expand cultural and tourism facilities, such as luxurious 5-star hotels, foreigners-only casinos, convention installations, spas, theme parks and more.
Having opened in April 2017 as the first resort complex in Korea, the ‘Paradise City’ comprises a 5-star hotel with 711 rooms, the largest foreigners-only casino in Korea, and a convention hall that can accommodate 1,600 persons. From September 2018, it has been operating a boutique hotel with 58 suite rooms, spa blended with Korean dry sauna culture, the largest recreation club in Northeast Asia, and an art exhibition space. In March 2019, it opened the Wonder Box, an indoor theme park with the concept of ‘amusement park in the evening’, presenting enjoyment both to foreign and local visitors.
To open it in 2021, the Caesars Resort Complex is under construction in Yeongjong-do by Caesars Entertainment headquartered in Las Vegas. The Caesars Resort Complex will consist of a luxury hotel with over 700 rooms, casino for foreigners only, convention facilities, live entertainment performing hall, signature spa and a swimming pool.
Adjacent to the Incheon International Airport, the Inspire Resort Complex is under construction led by Mohegan Gaming and Entertainment (MGE), the owner of Mohegan Sun casino located in Connecticut, to open in 2022. The resort complex will include a luxury hotel with over 1,250 rooms, foreigners-only casino, and indoor and outdoor theme parks. It will also operate a performing facility (arena) that can accommodate 15,000 audiences, staging Las Vegas-level fantastic performances all year round. It is expected to significantly contribute to spreading the Korean Wave.
The Incheon Free Economic Zone Authority expects the resort complex businesses to generate over 20,000 new jobs and production inducement effect of approximately KRW2 trillion (USD1680 million) annually. It also expects that the resort complex industry will conspicuously contribute to invigorating the regional economy and development of the MICE industry.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191210005029/en/
Contact information
Incheon Metropolitan City
Sang Kon Park
+82 32-440-3052
sangkon7@korea.kr
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 10:00:00 EEST | Press release
Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defies convention and empowers individuals to express their identity and bring out confidence. At the heart of this vision is the brand’s signature shadow enhancing makeup approach
Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 04:00:00 EEST | Press release
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe ’s Coverage of ESCMID Global Congress 202617.7.2026 04:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 01:00:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-treat, high-impact sites, including the scalp, nails, palms and soles, compared with placebo.1-5 These data build on the topline results from the Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled LATITUDE PsO 3001 and 3002 studies.2,6 In those studies, about 70% of patients treated with zasocitinib achieved static Physician Global Assessment (sPGA) 0/1 (clear or almost clear skin) at week 16, with a significantly greater Psoriasis Area and Severity Index (PASI) 75 response rate seen as early as w
Merz Completes Inaugural €450 Million Schuldschein Loan Issuance17.7.2026 00:36:00 EEST | Press release
The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful placement, Merz has further diversified its funding base by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom